Overview
- 5 inspections across 5 sites are on record.
- 2 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-09-13.
At a glance
Inspections
5
Sites
5
Observations
2
Career since
Jun 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Ramashanker Yadav, M.D. | 13 Sep 2024 | Human Drugs | |
| The City College of New York/CUNY | 16 Sep 2022 | Human Drugs | On file |
| Pharmaron (Exton) Lab Services LLC | 1 Feb 2019 | Human Drugs | On file |
| Sun Pharmaceutical Industries (prev. Ranbaxy) | 12 Jan 2018 | Human Drugs | |
| LABORATORIOS RUBIO SA | 23 Jun 2017 | Human Drugs | On file |
Sites inspected
Ramashanker Yadav, M.D.Ahmedabad, India1 insp.
The City College of New York/CUNYNew York, United States1 insp.
Pharmaron (Exton) Lab Services LLCExton, United States1 insp.
Sun Pharmaceutical Industries (prev. Ranbaxy)Gurugram, India1 insp.
LABORATORIOS RUBIO SACastellbisbal, Spain1 insp.
Co-investigators
Investigators who share inspections with this person.
Courtney N Long1 shared
Melkamu Getie Kebtie1 shared
Sheri L Stephenson1 shared
Himanshu Gupta1 shared
Sam H Haidar1 shared
Sripal R Mada1 shared
Full investigator report
Get the verbatim findings behind Seongeun Cho's 2 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site